
The GE Healthcare Allia IGS 7 angiography system.
News | Angiography | December 01, 2020
December 3, 2020 — GE Healthcare is introducing a new version of its robotic driven angiography system for image guided...

COVID-19 cardiology related content continues to be among the top performers on the DAIC website in November 2020. TAVR also topped headlines with Boston Scientific taking its Lotus valve off the market and a review of TAVR registry data showing it is now the dominant method of aortic valve replacement in the United States.
Feature | Cardiovascular Business | December 01, 2020 | Dave Fornell, Editor
December 1, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)...
December 1, 2020 — A recent publication demonstrated procedural efficiency for MitraClip transcatheter mitral valve...

One-year results off the PIONEER III study comparing the safety and efficacy of the Supreme HT drug-eluting stent (DES), to the Xience or Promus Durable Polymer DES showed it was equivalent in clinical performance to the market-leading DES. The results were presented at the 2020 American Heart Association (AHA) Scientific Session.
News | Stents | November 24, 2020
November 24, 2020 — One-year results off the PIONEER III study comparing the safety and efficacy of the Supreme HT (...

The Edwards Lifesciences Sapien 3 TAVR valve. The annual volume of TAVR has increased each year and in 2019 TAVR volume (72,991) exceeded all forms of SAVR (57,626), coinciding with the U.S. Food and Drug Administration (FDA) approval of TAVR for low-risk patients.
Feature | Heart Valve Technology | November 17, 2020
November 17, 2020 — Since the approval of the first transcatheter aortic valve replacement (TAVR) device in 2011, more...
Feature | Heart Valve Technology | November 17, 2020 | Dave Fornell, Editor
November 17, 2020 — Boston Scientific Corp. announced today it is immediately retiring the entire Lotus Edge...

The Women’s Heart Attack Research Program (HARP) study shows combining OCT and cardiac MRI can help detect the underlying cause of heart attacks in women who did not have blocked arteries.
News | Cardiac Imaging | November 17, 2020
November 17, 2020 — Diagnostic imaging techniques were able to find the underlying cause of heart attack in many women...

Omega-3 fish oil supplements did not help patients after a heart attack. Getty Images
News | Pharmaceuticals | November 17, 2020
November 17, 2020 — A daily dose of omega-3 fatty acids did not reduce the risk of cardiac events, including secondary...
News | Cath Lab | November 16, 2020
November 16, 2020 — The use of the more potent antiplatelet medication ticagrelor (Brilinta) was not superior to...

The FDA-Cleared XO Score is different. XO Score technology allows users to convert basic angioplasty balloons in the hospital's existing inventory into sophisticated scoring, cutting, and infusion/delivery devices.
November 13, 2020 — The new U.S. Food and Drug Administration (FDA) cleared XO Score system was successfully used to...

Figure 1: PROTECT III found, when compared to intra-aortic balloon pump (IABP), Impella use led to a 29% reduction in MACCE at 90 days.
News | Hemodynamic Support Devices | November 12, 2020
November 12, 2020 — Abiomed recently announced new PROTECT III study data that demonstrates reduced rates of MACCE (...
Videos | Coronavirus (COVID-19) | November 10, 2020
Keith Ellis, M.D., is the director of cardiovascular services and the director of the Chest Pain Center at Houston...

An example of radiation dose tracking software from Imalogix showing data on cath lab angiography cases. Photo by Dave Fornell
Feature | Radiation Dose Management | November 04, 2020 | Dave Fornell, Editor
More than a decade ago, there was an alarming, rapid rise in ionizing radiation exposure in the U.S. population that...
News | Drug-Eluting Balloons | November 03, 2020
November 3, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the Boston Scientific Ranger Drug-coated...
News | Robotic Systems | November 03, 2020
November 3, 2020 – Robocath, a company commercializing cardiovascular cath lab robotic systems, announced creation of...